Santosh B. Murthy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Santosh B. Murthy has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Yogesh Moradiya
Division of Neurosciences Critical Care
4 shared publications- Shreyansh Shah
Department of Neurology Duke University School of Medicine Durham NC
3 shared publications Wendy C. Ziai
Division of Neurosciences Critical Care
3 shared publicationsChethan P. Venkatasubba Rao
Department of Neurology, Baylor College of Medicine, 6501 Fannin, NB 302, Houston, TX 77030, USA; Department of Vascular Neurology and Neurocritical Care, Baylor College of Medicine, Houston, TX, USA
2 shared publicationsDaniel F. Hanley
From the Division of Neurosciences Critical Care, Department of Neurology (S.B.M., Y.M., W.C.Z.) and Division of Brain Injury Outcomes (D.F.H.), Johns Hopkins University School of Medicine, Baltimore, MD; and Department of Cerebrovascular Medicine, University of Glasgow, United Kingdom (J.D., K.R.L.).
2 shared publicationsEric M. Bershad
Department of Neurology, Baylor College of Medicine, 6501 Fannin, NB 302, Houston, TX 77030, USA; Department of Vascular Neurology and Neurocritical Care, Baylor College of Medicine, Houston, TX, USA
2 shared publications
Latest Publications
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract WMP108: Defining Optimal Thresholds for Achieving Clinical Benefit in Spontaneous Intraventricular Hemorrhage
Introduction: Fibrinolytic therapy for spontaneous intraventricular hemorrhage (IVH) appears to reduce mortality with uncertain benefit on long-term functional outcomes. Threshold for volume of IVH which responds to intraventricular fibrinolytic therapy with therapeutic benefit has not been determined. Methods: CLEAR III, a randomized, multi-center, double-blinded, placebo-controlled trial was conducted to determine if pragmatically employed external ventricular drainage (EVD) plus intraventricular Alteplase improved outcome, in comparison to EVD plus saline. We analyzed of IVH volume strata from study randomization: Large IVH: volume ≥50 mL; small IVH: volume3 signifying poor outcome). We performed logistic regression to evaluate outcomes by IVH volume group. Results: Among the 500 patients enrolled, 55 (11%) had IVH volumes >50 mL and 222 (44.4%) had IVH volume Conclusions: IVH volume >50mL may represent a cohort without identified benefit from fibrinolytic treatment. Defining an upper limit for IVH volume would benefit from a larger sample and other methods of achieving IVH reduction.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract WMP108: Defining Optimal Thresholds for Achieving Clinical Benefit in Spontaneous Intraventricular Hemorrhage
Introduction: Fibrinolytic therapy for spontaneous intraventricular hemorrhage (IVH) appears to reduce mortality with uncertain benefit on long-term functional outcomes. Threshold for volume of IVH which responds to intraventricular fibrinolytic therapy with therapeutic benefit has not been determined. Methods: CLEAR III, a randomized, multi-center, double-blinded, placebo-controlled trial was conducted to determine if pragmatically employed external ventricular drainage (EVD) plus intraventricular Alteplase improved outcome, in comparison to EVD plus saline. We analyzed of IVH volume strata from study randomization: Large IVH: volume ≥50 mL; small IVH: volume3 signifying poor outcome). We performed logistic regression to evaluate outcomes by IVH volume group. Results: Among the 500 patients enrolled, 55 (11%) had IVH volumes >50 mL and 222 (44.4%) had IVH volume Conclusions: IVH volume >50mL may represent a cohort without identified benefit from fibrinolytic treatment. Defining an upper limit for IVH volume would benefit from a larger sample and other methods of achieving IVH reduction.
- 1 January 2016
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 78 (1) , 71-76
Haptoglobin 2-2 Genotype Is Associated With Cerebral Salt Wasting Syndrome in Aneurysmal Subarachnoid Hemorrhage
BACKGROUND:. Haptoglobin (Hp) genotype has been shown to be a predictor of clinical outcomes in subarachnoid hemorrhage. Cerebral salt wasting (CSW) has
- 1 January 2016
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 78 (1) , 71-76
Haptoglobin 2-2 Genotype Is Associated With Cerebral Salt Wasting Syndrome in Aneurysmal Subarachnoid Hemorrhage
BACKGROUND:. Haptoglobin (Hp) genotype has been shown to be a predictor of clinical outcomes in subarachnoid hemorrhage. Cerebral salt wasting (CSW) has
- 1 November 2015
- Published by Wolters Kluwer Health in Stroke
- Vol. 46 (11) , 3088-3092
Perihematomal Edema and Functional Outcomes in Intracerebral Hemorrhage
Background and Purpose—Perihematomal edema (PHE) is associated with poor outcomes after intracerebral hemorrhage (ICH). PHE evolves in the early period after ICH, providing a therapeutic target and window for intervention. We studied the effect of PHE volume expansion in the first 72 hours (iPHE) and its relationship with functional outcomes. Methods—We used data contained in the Virtual International Stroke Trials Archive. We included patients who presented within 6 hours of symptom onset, had baseline clinical, radiological, and laboratory data, and further computed tomographic scan data at 72 hours and 90-day functional outcomes. We calculated iPHE and used logistic regression analysis to assess relationships with outcome. We adjusted for confounding variables and the primary outcome measure poor day-90 outcome (defined as modified Rankin Scale score of ≥3. We performed subgroup analyses by location and by volume of ICH. Results—We included 596 patients with ICH. Median baseline hematoma volume was 15.0 mL (IQR, 7.9–29.2) and median baseline PHE volume was 8.7 mL (IQR, 4.5–15.5). Hematoma expansion occurred in 122 (34.9%) patients. Median iPHE was 14.7 mL (IQR, 6.6–30.3). The odds of a poor outcome were greater with increasing iPHE (OR, 1.78; CI, 1.12–2.64 per mL increase). Subgroup analyses showed that iPHE was only related to poor functional outcomes in basal ganglia and small (Conclusions—Absolute increase in PHE during 72 hours was associated with worse functional outcomes after ICH, particularly with basal ganglia ICH and hematomas <30 mL.
- 1 November 2015
- Published by Wolters Kluwer Health in Stroke
- Vol. 46 (11) , 3088-3092
Perihematomal Edema and Functional Outcomes in Intracerebral Hemorrhage
Background and Purpose—Perihematomal edema (PHE) is associated with poor outcomes after intracerebral hemorrhage (ICH). PHE evolves in the early period after ICH, providing a therapeutic target and window for intervention. We studied the effect of PHE volume expansion in the first 72 hours (iPHE) and its relationship with functional outcomes. Methods—We used data contained in the Virtual International Stroke Trials Archive. We included patients who presented within 6 hours of symptom onset, had baseline clinical, radiological, and laboratory data, and further computed tomographic scan data at 72 hours and 90-day functional outcomes. We calculated iPHE and used logistic regression analysis to assess relationships with outcome. We adjusted for confounding variables and the primary outcome measure poor day-90 outcome (defined as modified Rankin Scale score of ≥3. We performed subgroup analyses by location and by volume of ICH. Results—We included 596 patients with ICH. Median baseline hematoma volume was 15.0 mL (IQR, 7.9–29.2) and median baseline PHE volume was 8.7 mL (IQR, 4.5–15.5). Hematoma expansion occurred in 122 (34.9%) patients. Median iPHE was 14.7 mL (IQR, 6.6–30.3). The odds of a poor outcome were greater with increasing iPHE (OR, 1.78; CI, 1.12–2.64 per mL increase). Subgroup analyses showed that iPHE was only related to poor functional outcomes in basal ganglia and small (Conclusions—Absolute increase in PHE during 72 hours was associated with worse functional outcomes after ICH, particularly with basal ganglia ICH and hematomas <30 mL.
- Open Access
- 6 October 2015
- Published by Springer Nature in Critical Care
- Vol. 19 (1) , 352
Dehydroepiandrosterone sulphate: diabolical hormone or epiphenomenon in aneurysmal subarachnoid hemorrhage?
- 6 October 2015
- Published by Springer Nature in Critical Care
- Vol. 19 (1) , 352
Open AccessDehydroepiandrosterone sulphate: diabolical hormone or epiphenomenon in aneurysmal subarachnoid hemorrhage?
- 3 September 2015
- Published by Springer Nature in Neurocritical Care
- Vol. 24 (3) , 389-396
Incidence, Predictors, and Outcomes of Ventriculostomy-Associated Infections in Spontaneous Intracerebral Hemorrhage
Background The impact of ventriculostomy-associated infections (VAI) on intracerebral hemorrhage (ICH) outcomes has not been clearly established, although prior studies have attempted to address the incidence and predictors of VAI. We aimed to explore VAI characteristics and its effect on ICH outcomes at a population level. Methods ICH patients requiring ventriculostomy with and without VAI were identified from 2002 to 2011 Nationwide Inpatient Sample using ICD-9 codes. A retrospective cohort study was performed. Demographics, comorbidities, hospital characteristics, inpatient outcomes, and resource utilization measures were compared between the two groups. Pearson’s Chi-square and Wilcoxon–Mann–Whitney tests were used for categorical and continuous variables, respectively. Logistic regression was used to analyze the predictors of VAI. Results We included 34,238 patients in the analysis, of whom 1934 (5.6 %) had VAI. The rate of ventriculostomy utilization in ICH increased from 5.7 % in 2002–2003 to 7.0 % in 2010–2011 (trend p < 0.001) and the rate of VAI also showed a gradual upward trend from 6.1 to 7.0 % across the same interval (trend p < 0.001). The VAI group had significantly higher inpatient mortality (41.2 vs. 36.5 %, p < 0.001) and it remained higher after controlling for baseline demographics, hospital characteristics, comorbidity, and systemic infections (adjusted OR 1.38, 95 % CI 1.22–1.46, p < 0.001). The VAI group had longer length of hospital stay and higher inflation adjusted cost of care. Predictors of VAI included higher age, males, higher Charlson’s comorbidity scores, longer length of stay, and presence of systemic infections mainly pneumonia and sepsis. Conclusion VAI resulted in higher inpatient mortality, more unfavorable discharge disposition, and higher resource utilization measures in ICH patients. Steps to mitigate VAI may help improve ICH outcomes and decrease hospital costs.
- 3 September 2015
- Published by Springer Nature in Neurocritical Care
- Vol. 24 (3) , 389-396
Incidence, Predictors, and Outcomes of Ventriculostomy-Associated Infections in Spontaneous Intracerebral Hemorrhage
Background The impact of ventriculostomy-associated infections (VAI) on intracerebral hemorrhage (ICH) outcomes has not been clearly established, although prior studies have attempted to address the incidence and predictors of VAI. We aimed to explore VAI characteristics and its effect on ICH outcomes at a population level. Methods ICH patients requiring ventriculostomy with and without VAI were identified from 2002 to 2011 Nationwide Inpatient Sample using ICD-9 codes. A retrospective cohort study was performed. Demographics, comorbidities, hospital characteristics, inpatient outcomes, and resource utilization measures were compared between the two groups. Pearson’s Chi-square and Wilcoxon–Mann–Whitney tests were used for categorical and continuous variables, respectively. Logistic regression was used to analyze the predictors of VAI. Results We included 34,238 patients in the analysis, of whom 1934 (5.6 %) had VAI. The rate of ventriculostomy utilization in ICH increased from 5.7 % in 2002–2003 to 7.0 % in 2010–2011 (trend p < 0.001) and the rate of VAI also showed a gradual upward trend from 6.1 to 7.0 % across the same interval (trend p < 0.001). The VAI group had significantly higher inpatient mortality (41.2 vs. 36.5 %, p < 0.001) and it remained higher after controlling for baseline demographics, hospital characteristics, comorbidity, and systemic infections (adjusted OR 1.38, 95 % CI 1.22–1.46, p < 0.001). The VAI group had longer length of hospital stay and higher inflation adjusted cost of care. Predictors of VAI included higher age, males, higher Charlson’s comorbidity scores, longer length of stay, and presence of systemic infections mainly pneumonia and sepsis. Conclusion VAI resulted in higher inpatient mortality, more unfavorable discharge disposition, and higher resource utilization measures in ICH patients. Steps to mitigate VAI may help improve ICH outcomes and decrease hospital costs.
- 1 December 2014
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 21 (12) , 2088-2091
In-hospital outcomes of aneurysmal subarachnoid hemorrhage associated with cocaine use in the USA
- 1 December 2014
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 21 (12) , 2088-2091
In-hospital outcomes of aneurysmal subarachnoid hemorrhage associated with cocaine use in the USA
- 1 February 2014
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 21 (2) , 203-206
The SILK flow diverter in the treatment of intracranial aneurysms
- 1 February 2014
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 21 (2) , 203-206
The SILK flow diverter in the treatment of intracranial aneurysms
- 7 November 2013
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 30 (6) , 318-325
Neurogenic Stunned Myocardium Following Acute Subarachnoid Hemorrhage
Neurogenic stunned myocardium (NSM) is a triad of transient left ventricular dysfunction, electrocardiogram changes, and elevation in cardiac enzymes, often mimicking a myocardial infarction. It has been described following acute brain injury. The purported mechanism is catecholamine excess resulting in cardiac dysfunction. From the clinical standpoint, the most frequently encountered electrocardiographic changes are QTc prolongation and ST-T changes, with modest elevations in troponin levels. Basal and mid-ventricular segments of the left ventricle are most commonly involved. NSM poses therapeutic challenges when it occurs secondary to aneurysmal subarachnoid hemorrhage, particularly in the setting of coexisting vasospasm. Overall, NSM carries good prognosis if recognized early, with appropriate management of hemodynamic and cardiopulmonary parameters.
- 7 November 2013
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 30 (6) , 318-325
Neurogenic Stunned Myocardium Following Acute Subarachnoid Hemorrhage
Neurogenic stunned myocardium (NSM) is a triad of transient left ventricular dysfunction, electrocardiogram changes, and elevation in cardiac enzymes, often mimicking a myocardial infarction. It has been described following acute brain injury. The purported mechanism is catecholamine excess resulting in cardiac dysfunction. From the clinical standpoint, the most frequently encountered electrocardiographic changes are QTc prolongation and ST-T changes, with modest elevations in troponin levels. Basal and mid-ventricular segments of the left ventricle are most commonly involved. NSM poses therapeutic challenges when it occurs secondary to aneurysmal subarachnoid hemorrhage, particularly in the setting of coexisting vasospasm. Overall, NSM carries good prognosis if recognized early, with appropriate management of hemodynamic and cardiopulmonary parameters.